Tecentriq 840 MG/14 ML vial 14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3WQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,345
Award facts
- Contract value 100% obligated
- $9,344.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,344.66 to AmerisourceBergen Drug Corp for the supply of Tecentriq 840 mg/14 ml vials on January 28, 2026. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 19, 2026, with performance executed from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a major federal contractor competing on a full and open basis, AmerisourceBergen's federal contract awards demonstrate significant capability in fulfilling government medical supply needs ranging from small-value transactions to substantial orders, with this particular delivery order for Tecentriq—a cancer treatment medication—reflecting the company's ongoing role in supporting Department of Defense healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FG3WQ?
SPE2DR26FG3WQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FG3WQ worth?
The government has obligated $9,345 on SPE2DR26FG3WQ.
Is contract SPE2DR26FG3WQ an order under another contract?
Yes. SPE2DR26FG3WQ is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3WQ competed?
The extent of competition for SPE2DR26FG3WQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award